Dr. Joshua Pink

Joshua is an Associate Professor in Health Economics in the Centre for Digital Innovations in Health & Social Care at the University of Bradford.

After completing a PhD in health economics, he has previously worked as a health economist and statistician, first in the Medical School at the University of Warwick, then at NICE (the National Institute for Health and Care Excellence), and finally in the School of Health and Society at the University of Salford.

At NICE, he worked on statistical and health economic reviewing and modelling to support a range of national guidance. He was responsible for the development of original economic modelling on chronic kidney disease, c difficile infections, tuberculosis, preventing sexually transmitted infections and weight management, as well as adapting pre-existing modelling in a number of other areas (including diabetes and increasing uptake of routine vaccinations).

At the University of Warwick, he worked in the Clinical Trials Unit, conducting health economic and statistical analyses alongside trials on surgery, orthopaedics, cancer and parental interventions, in particular programmes to provide support to vulnerable parents. He also did health economic modelling on a project to inform decisions made by the JCVI (Joint Committee on Vaccination and Immunisation). This project was run jointly with Public Health England, and informed the introduction of both the UK meningitis C vaccination programme, and the vaccination of boys against HPV.

His current research interests are around health technology assessment and cost-effectiveness analysis, in particular evaluations of digital health technologies, including patient and public preferences as part of decision making, and developing frameworks for disinvestment in older or less effectiveness interventions or practices.